Skip to content
AnalystLens
Back to ROIVIncome Statement

Roivant Sciences Revenue 2021-2027 | ROIV

Annual FY2021–FY2026 · quarterly through Q1 FY2027

Latest annual · FY2026

$8.3M

−71.6%YoY vs FY2025Source: 10-KFY2026

From $23.8M in FY2021 to $8.3M in FY2026: 0.3× in 5 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY27$1M−33.5%Not reportedNot reportedNot reported
FY26$2M−72.8%$2M−64.9%$2M−77.8%$3M−66.7%
FY25$8M−63.1%$4M+22.7%$9M−42.1%$8M+193.2%
FY24$22M+400.7%$4M−70.9%$16M−8.7%−$8M−242.1%
FY23$4M−44.2%$13M−10.4%$17M−29.9%−$2M−125.7%
Share19%16%31%34%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionDeclining
CAGR

−19.1%

FY2021
$23.8M
FY2026
$8.3M

5 years selected · on the chart

Revenue History

Year-over-year comparison from 10-K annual reports

  1. $8.3M
YoY changeLargest recent move+132.3%in FY22Latest −71.6%

Revenue, period by period

PeriodValueChangeSource
FY2026$8.3M−71.6%10-K
FY2025$29.1M−11.2%10-K
FY2024$32.7M+3.8%10-K
FY2023$31.5M−43.0%10-K
FY2022$55.3M+132.3%10-K
FY2021$23.8M—10-K

What is revenue?

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

What is Roivant Sciences's current revenue?

Roivant Sciences (ROIV) annual revenue for 2026 was $8.3M, a 71.57% decline from 2025. Roivant Sciences revenue for the quarter ending June 30, 2026 was $1.4M.

What was Roivant Sciences's revenue in 2025?

Roivant Sciences annual revenue for 2025 was $29.1M, a 11.19% decline from 2024.

What was Roivant Sciences's revenue in 2024?

Roivant Sciences annual revenue for 2024 was $32.7M, a 3.75% increase from 2023.

What is Roivant Sciences's 5-year revenue CAGR?

Roivant Sciences revenue grew at a compound annual growth rate (CAGR) of 19.07% from FY2021 to FY2026, going from $23.8M to $8.3M over 5 years.

Company
Roivant Sciences
Ticker
ROIV
Sector
Healthcare
Industry
Pharmaceutical Preparations